IMR Press / FBL / Volume 16 / Issue 4 / DOI: 10.2741/3802

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Proliferation unleashed: the role of Skp2 in vascular smooth muscle cell proliferation
Show Less
1 The Bristol Heart Institute, University of Bristol, Bristol BS2 8HW, UK
2 Department of Cardiovascular Medicine and Medical Research, Mackay Memorial Hospital, and the Department of Medicine, Mackay Medical College, and Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan

Academic Editor: Tao Wang

Front. Biosci. (Landmark Ed) 2011, 16(4), 1517–1535;
Published: 1 January 2011
(This article belongs to the Special Issue Signalling pathways in cardiovascular function and diseases)

Vascular smooth muscle cell proliferation plays a major role in the development of numerous vascular pathologies. Understanding the molecular mechanisms that regulate smooth muscle cell proliferation is therefore essential for the development of new therapies for the treatment of these pathologies. Skp2 is an F-box protein component of the SCFSkp2 ubiquitin-ligase that controls cellular proliferation by regulating the ubiquitination and degradation of several cell-cycle regulatory proteins, including the cyclin-dependent kinase inhibitor, p27Kip1. This review discusses the recent literature on the function and regulation of Skp2 in smooth muscle cells, which is emerging as a key player in the control of smooth muscle cell proliferation during vascular disease.

Back to top